1Internal Medicine, SUNY Downstate Medical Center, Brooklyn, United States
2Department of Pathology, SUNY Downstate Medical Center, Brooklyn, United States
American Journal of Medical Case Reports.
2020,
Vol. 8 No. 5, 115-118
DOI: 10.12691/ajmcr-8-5-2
Copyright © 2020 Science and Education PublishingCite this paper: Evan Botti MD, Michelle Likhtshteyn MD, Ghulam Ilyas MD, Evan Marzouk, Kakin R. Iong MD. Drug Induced Liver Injury due to Hydralazine: A Case Report and Review of Literature.
American Journal of Medical Case Reports. 2020; 8(5):115-118. doi: 10.12691/ajmcr-8-5-2.
Correspondence to: Michelle Likhtshteyn MD, Internal Medicine, SUNY Downstate Medical Center, Brooklyn, United States. Email:
michelle.likhtshteyn@downstate.eduAbstract
Drug Induced Liver Injury (DILI)accounts for around 11% of all Acute Liver Failure (ALF)cases and are usually associated with over the counter supplements [1]. Hepatotoxicity due to Hydralazine is not commonly reported [2]. Often times DILI may have variable presentations and latency times, making diagnosis difficult. Here we present a 70-year-oldfemale with multiple medical problems who presented to the hospital with jaundice and abdominal pain and concluded to have hydralazine induced liver injury.
Keywords